Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2005 Dec 5;5(4):649–660. doi: 10.1002/hep.1840050422

Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3†

Peggy J Macphee 1, Vincent J Dindzans 1,‡, Lai‐Sum Fung 1, Gary A Levy 1,§,✉
PMCID: PMC7165583  PMID: 2991107

Abstract

The acute and chronic effects of mouse hepatitis virus type 3 on the microcirculation of the liver in both semisusceptible C3HeB/FeJ and fully resistant A/J mice were studied. In the C3HeB/FeJ mice, abnormalities of microcirculatory flow were noted as early as 12 hr after infection and by 24 hr, localized avascular foci appeared. Disturbances were characterized by granular blood flow, sinusoidal microthrombi, distortion of sinusoids by edematous hepatocytes and necrotic lesions. Following the acute infection, Day 10, two patterns of chronic disease were observed. Eighty percent of the mice developed chronic granulomatous hepatitis whereas in the remaining 20% a more severe chronic aggressive hepatitis was observed which was characterized by ongoing hepatocellular necrosis and a marked mononuclear cell infiltrate. In both cases, in vivo microcirculatory abnormalities were found predominantly around visible lesions. Onset of the microcirculatory abnormalities was found to be concomitant with a rise in monocyte related procoagulant activity. Procoagulant activity rose acutely and remained elevated throughout the chronic phase but was higher in animals with severe disease. In contrast to the above, normal blood flow and histology were seen in the resistant A/J mice at all times following infection, and procoagulant activity remained at basal levels despite active viral replication as demonstrated by immunofluorescence studies and recovery of infectious virus. These observations suggest a role for monocyte procoagulant activity in the development of microcirculatory abnormalities following mouse hepatitis virus type 3 infection which may be important in the pathogenesis of the disease.

†

This work is dedicated to Aron M. Rappaport on the occasion of his 80th birthday.

References

  • 1. Greenway CV, Stark RD. Hepatic vascular bed. Physiol Rev 1971; 51: 23–65. [DOI] [PubMed] [Google Scholar]
  • 2. Rappaport AM. The microcirculatory acinar concept of normal and pathological hepatic structure. Beitr Pathol Bd 1976; 157: 215–243. [DOI] [PubMed] [Google Scholar]
  • 3. Gumucio JJ, Miller DL. Functional implications of liver cell heterogeneity. Gastroenterology 1981; 80: 393–403. [PubMed] [Google Scholar]
  • 4. Chen FH, Gumucio JJ, Ho NH. et al. Hepatocytes of zones 1 and 3 conjugated sulfobromopthalein with glutathione. Gastroenterology 1984; 4: 467–476. [DOI] [PubMed] [Google Scholar]
  • 5. Nakata K, Fujimoto K. Relationship between liver cell injury and circulatory disturbances in the development of CCl4 toxicity. Acta Pathol Japan 1973; 23: 667–673. [DOI] [PubMed] [Google Scholar]
  • 6. Chernukh AM, Kwalenko NY. Disorders of microcirculation and vascular tissue permeability in acute diffuse experimental hepatitis. Bibl Anat 1973; 12: 484–489. [PubMed] [Google Scholar]
  • 7. Wege H, Sidell S, ter Meulen V. The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immun 1982; 99: 131–163. [DOI] [PubMed] [Google Scholar]
  • 8. Levy GA, MacPhee PJ, Fung LS. et al. The effect of mouse hepatitis virus infection on the microcirculation of the liver. Hepatology 1983; 3: 964–973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Levy GA, Leibowitz JL, Edgington TS. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med 1981; 154: 1150–1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Le Provost C, Virelizier JL, Dupuy JM. Immunopathology of MHV‐3 infection. III. Clinical and virologic observations of a persistent viral infection. J Exp Med 1975; 115: 640–643. [PubMed] [Google Scholar]
  • 11. Leibowitz JL, Fung LS, Levy GA. A sensitive radioimmunoassay for the detection of antibody to mouse hepatitis. J Virol Methods 1983; 3: 255–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Levy GA, Edgington TS. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med 1980; 151: 1232–1244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Mims CA. Aspects of the pathogenesis of virus diseases. Bacteriol Rev 1964; 28: 30–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Buchmeier MJ, Welch RM, Dutko FJ. et al. The virology and immunobiology of lymphocytic choriomeningitis infection. Adv Immunol 1980; 30: 275–331. [DOI] [PubMed] [Google Scholar]
  • 15. Schindler L, Engler H, Kirchner H. Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice. Infect Immunol 1982; 35: 869–873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. MacNaughton MR, Patterson S. Mouse hepatitis virus‐3 infection of C57, A/Sn and A/J strain mice and their macrophages. Arch Virol 1980; 66: 71–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Zimmerman TS, Frcier J, Rothberger H. Blood coagulation and the inflammatory response. Semin Hematol 1977; 14: 391–408. [PubMed] [Google Scholar]
  • 18. Levy GA, Helin H, Edgington TS. The pathobiology of viral hepatitis and immunologic activation of the coagulation protease network. Semin Liver Dis 1984; 4: 59–68. [DOI] [PubMed] [Google Scholar]
  • 19. Thompson NM, Simpson IS, Peters DK. A quantitative evaluation of anti‐coagulants in experimental nephrotic nephritis. Clin Exp Immunol 1975; 19: 301–312. [PMC free article] [PubMed] [Google Scholar]
  • 20. Sundsmo JS, Fair DS. Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction. Clin Physiol Biochem 1983; 1: 225–284. [PubMed] [Google Scholar]
  • 21. Bar‐Shevit R, Kahn A, Wilner GD. Monocyte Chemotaxis: stimulation by specific exosite region in thrombin. Science 1983; 220: 728–731. [DOI] [PubMed] [Google Scholar]
  • 22. Edgington TS, Helin H, Gregory SA. et al. Cellular pathways and signals for the induction, biosynthesis of initiators of the coagulation protease cascade and of plasminogen activators in cells of the monocyte lineage Monocytes, macrophages and inflammation. Amsterdam: Elsevier North‐Holland, 1984. (in press). [Google Scholar]
  • 23. Geczy CL. The role of lymphokines in delayed type hypersensitivity reactions. Springer Semin Immunopathol 1984; 7: 321–346. [DOI] [PubMed] [Google Scholar]
  • 24. Dindzans VJ, MacPhee PJ, Fung LS, et al. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo. J Immunol (in press). [PubMed]
  • 25. Rappaport AM. Physioanatomical basis of toxic liver injury In: Farber E, Fisher MM, eds. Toxic injury of the liver. New York: Marcel Dekker Publishers, 1973: 1–57. [Google Scholar]
  • 26. Rappaport AM, MacDonald A. Study of the effects of acetaminophen (paracetamol) on the hepatic microcirculation In: Grayson J, Zingg W, eds. Microcirculation: first world congress on microcirculation. University of Toronto 1975, Vol 1 New York: Plenum Press, 1975: page 350. [Google Scholar]
  • 27. Nagler A. The circulatory manifestations of bacterial endotoxemia In: Kaley G, Altura BM, eds. Microcirculation, Vol 3 Baltimore, Maryland: University Park Press, 1980: 107–117. [Google Scholar]
  • 28. Bloch EH. Microscopic observations of the circulating blood in the bulbar conjunctiva in man in health and disease. Ergebenisse der Anatomie und Entwicklungs Geshichte 1956; 35: 1–98. [PubMed] [Google Scholar]
  • 29. Reubner BH, Hirano T, Slusser RJ. Electron microscopy of the hepatocellular and Kupffer cell lesion of mouse hepatitis with particular reference to the effect of cortisone. Am J Pathol 1967; 51: 163–189. [PMC free article] [PubMed] [Google Scholar]
  • 30. McCluskey RS, Urbaschek R, McCluskey PA. et al. In vivo studies of the responses of the liver to endotoxin. Klin Wochenschr 1982; 60: 749–751. [DOI] [PubMed] [Google Scholar]
  • 31. Goodman ML, Way BA, Irwin JW. The inflammatory response to endotoxin. J Pathol 1979; 128: 7–14. [DOI] [PubMed] [Google Scholar]
  • 32. Sabesin SM. Electron microscopy of hypersensitivity reactions: allergic hepatic necrosis. Am J Pathol 1963; 42: 743–754. [PMC free article] [PubMed] [Google Scholar]
  • 33. Mondelli M, Eddleston ALWF. Mechanisms of liver cell injury in acute and chronic hepatitis B. Semin Liver Dis 1984; 4: 47–58. [DOI] [PubMed] [Google Scholar]
  • 34. Schwartz BS, Levy GA, Edgington TS. Immune complex induced human monocyte procoagulant activity. II. Cellular kinetics and metabolic requirements. J Immunol 1982; 128: 1037–44. [PubMed] [Google Scholar]

Articles from Hepatology (Baltimore, Md.) are provided here courtesy of Wiley

RESOURCES